Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6482159 | 0.85 | LMNA (0.31) | LMNAKMT2A | |
| SCHEMBL6482031 | 0.84 | MAPK1 (0.35) | MAPK1LMNAKMT2A | |
| SCHEMBL5183084 | 0.83 | ALDH1A1 (0.39) | MAPK1LMNAKMT2A | |
| SCHEMBL6493541 | 0.82 | — | — | |
| SCHEMBL6492570 | 0.82 | KMT2A (0.37) | MAPK1LMNAKMT2A | |
| SCHEMBL6481307 | 0.82 | LMNA (0.37) | MAPK1LMNAKMT2A | |
| SCHEMBL6480815 | 0.82 | — | — | |
| SCHEMBL5194233 | 0.80 | ALDH1A1 (0.40) | MAPK1LMNA | |
| SCHEMBL6492677 | 0.80 | ALDH1A1 (0.32) | — | |
| SCHEMBL6490242 | 0.80 | ALDH1A1 (0.41) | MAPK1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050256048-A1 | Selective androgen receptor modulators and methods for their identification, design and use | SALVATI MARK E | 2005-11-17 | — | — | US | disclosed |
| US-20050090398-A1 | Novel tetrazole derivative useful as herbicides | YANAGI AKIHIKO (JP) | 2005-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256048-A1 | Selective androgen receptor modulators and methods for their identification, design and use | AR, FSHR, LHCGR | MAPK1 3603/4885LMNA 3902/4885KMT2A 1319/4885 |
| US-20050090398-A1 | Novel tetrazole derivative useful as herbicides | DDT, TTI1, CYP1A1 | MAPK1 2914/4885LMNA 4295/4885KMT2A 1800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.